Althaea Officinalis Homeopathic Pills Recall Due to Failed Identity Testing
Washington Homeopathic Products is recalling Althaea Officinalis 6X Irritable Bladder Sucrose/Lactose Pills distributed nationwide because test results failed to confirm the product's identity using HPTLC analysis.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses or injuries. The hazard is a failed identity test—a labeling/identification defect that does not describe an immediate safety threat to consumers. The recall addresses a manufacturing/quality control issue rather than a known health risk.
Plain-English summary
Washington Homeopathic Products, Inc. is recalling Althaea Officinalis 6X Irritable Bladder Sucrose/Lactose Pills, packaged as 4 Dram units, due to out-of-specification test results obtained during identification testing based on HPTLC (High-Performance Thin-Layer Chromatography) analysis.
The recalled product was distributed nationwide in the USA. The affected lot is Lot # 29377 with an expiration date of 8/17/2026, totaling 10 bottles.
Consumers who have purchased this product should stop using it. If you have questions or require additional information about the recall, contact the recalling firm, Washington Homeopathic Products, Inc., located at 260 JR Hawvermale Way, Berkeley Springs, WV 25411.
The recalled product
- Product
- Althaea Officinalis 6X, Iritable Bladder* Sucrose/Lactose Pills, packaged as 4 Dram, WHP Homeopathic Medicine, Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV 25411.
- Manufacturer
- Washington Homeopathic Products, Inc.
- Category
- Drug — Homeopathic Medicine
- Hazard
- failed-identity-testing
- mis-identification
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 29377
- Exp 8/17/2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27